USANA Q3 2026 net loss attributable to USANA narrows 15% year over year to $5.56 million

• USANA Health Sciences’ third-quarter FY26 net loss attributable to shareholders narrowed 15% year over year to $5.56 million.
• Net sales fell year over year to $205.89 million, while Core Nutritional active customers declined 8% to 356,000.
• Hiya active monthly subscribers climbed 18% sequentially to 195,500 following increased customer-acquisition spending.
• FY26 guidance now projects a $16 million net loss, 45% wider than previously forecast, with net sales approaching $900 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. USANA Health Sciences Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202611031605BIZWIRE_USPR_____20261103_BW898830) on November 03, 2026, and is solely responsible for the information contained therein.